These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 28546106)
21. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes. Desai C; Prabhakar B Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555 [TBL] [Abstract][Full Text] [Related]
22. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Wang S; Ding Y; Yao Y Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873 [TBL] [Abstract][Full Text] [Related]
23. Effect of HPbetaCD on solubility and transdermal delivery of capsaicin through rat skin. Zi P; Yang X; Kuang H; Yang Y; Yu L Int J Pharm; 2008 Jun; 358(1-2):151-8. PubMed ID: 18417302 [TBL] [Abstract][Full Text] [Related]
24. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Cirri M; Bragagni M; Mennini N; Mura P Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833 [TBL] [Abstract][Full Text] [Related]
25. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin. Lu Y; Zhang T; Tao J; Ji G; Wang S Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204 [TBL] [Abstract][Full Text] [Related]
28. Meloxicam β-cyclodextrin transdermal gel: physicochemical characterization and in vitro dissolution and diffusion studies. Rasool BK; Gareeb RH; Fahmy SA; Rasool AA Curr Drug Deliv; 2011 Jul; 8(4):381-91. PubMed ID: 21453259 [TBL] [Abstract][Full Text] [Related]
29. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
30. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Ramirez MA; Borja NL Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661 [TBL] [Abstract][Full Text] [Related]
31. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties. Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120 [TBL] [Abstract][Full Text] [Related]
32. Improvement on solubility of fluticasone propionate with cyclodextrins by mechanochemical activation. Dai J; Liang X; Su W Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):799-806. PubMed ID: 25796157 [TBL] [Abstract][Full Text] [Related]
33. [Inhibition effect of epalrestat on rat lens osmotic expansion]. Ji LX; Shen N; Li CN; Liu Q; Huan Y; Shen ZF Yao Xue Xue Bao; 2009 Oct; 44(10):1107-11. PubMed ID: 20055132 [TBL] [Abstract][Full Text] [Related]
34. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin. Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932 [TBL] [Abstract][Full Text] [Related]
35. Molecular interactions of the inclusion complexes of hinokitiol and various cyclodextrins. Suzuki R; Inoue Y; Limmatvapirat S; Murata I; Kanamoto I AAPS PharmSciTech; 2017 Oct; 18(7):2717-2726. PubMed ID: 28299622 [TBL] [Abstract][Full Text] [Related]
36. Utilization of Gelling Polymer to Formulate Nanoparticles Loaded with Epalrestat-Cyclodextrin Inclusion Complex: Formulation, Characterization, In-Silico Modelling and In-Vivo Toxicity Evaluation. Alvi Z; Akhtar M; Rahman NU; Hosny KM; Sindi AM; Khan BA; Nazir I; Sadaquat H Polymers (Basel); 2021 Dec; 13(24):. PubMed ID: 34960901 [TBL] [Abstract][Full Text] [Related]
37. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631 [TBL] [Abstract][Full Text] [Related]